Prestige Consumer Healthcare PBH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Prestige Consumer Healthcare (PBH) Core Market Data and Business Metrics
Latest Closing Price
$85.73Price-Earnings Ratio
20.86Total Outstanding Shares
49.41 Million SharesDividend
No dividendSIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
660 White Plains Rd., Tarrytown, NY, 10591
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities | $262.95 Million |
| Net Cash Flow From Financing Activities | $-250.01 Million |
| Net Cash Flow, Continuing | $-10.71 Million |
| Net Cash Flow From Investing Activities | $-23.66 Million |
| Net Cash Flow | $-8.53 Million |
| Net Cash Flow From Operating Activities, Continuing | $262.95 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Diluted Average Shares | $150.43 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Income/Loss From Continuing Operations After Tax | $205.95 Million |
| Income/Loss From Continuing Operations Before Tax | $261.33 Million |
| Income Tax Expense/Benefit, Deferred | $17.71 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $205.95 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $215.41 Million |
| Comprehensive Income/Loss | $215.41 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $9.46 Million |
| Other Comprehensive Income/Loss | $215.41 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Inventory | $156.22 Million |
| Other Current Liabilities | $51.21 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Other Non-current Assets | $544.72 Million |
| Liabilities And Equity | $3.32 Billion |
| Assets | $3.32 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||